Wanbury cash flow

Latest FY26

Cash from operations: ₹31.5cr+20.8% on FY25
Capital spending: ₹59.1cr+20.5% on FY25
Free cash flow: −₹27.5cr−₹22.9 cr in FY25
Cash from financing: ₹22.4cr−12.9% on FY25

₹ crore except per share

Tap a line for its trend	Last 12Mto Jun 2026	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Changes in working capital
Adjustments to reconcile profit — non-cash items						FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	—	14.3	13.3	13.0	12.4
	—	30.0	37.0	0.0	21.4
	—	0.0	0.0	−0.4	−0.4
	—	−0.0	−0.1	0.0	0.0
	—	1.6	1.1	0.0	0.9
	—	−0.4	−0.2	0.0	2.6
	—	3.6	0.0	28.9	0.2
	—	0.0	−2.0	0.0	0.0
	—	0.9	0.0	−18.4	0.0
	—	−12.9	−1.7	14.0	27.7
	—	−26.3	−25.4	0.0	−5.3
	—	0.0	0.0	−20.3	0.0
	—	−0.5	−1.1	0.0	0.3
	—	0.0	−0.1	0.2	−0.3
	—	−8.4	0.5	−1.6	4.9
	—	1.0	−1.0	0.0	0.0
	—	−32.0	−22.1	−5.0	−26.6
	—	−1.4	0.1	−32.1	−3.7
	—	0.9	−1.6	0.0	0.0
	—	−1.2	−0.6	−5.9	−5.4
	—	2.2	0.5	0.4	−0.3
	—	2.3	1.4	0.6	1.9
Cash from operating activities
	50.8	59.8	29.6	30.8	−10.3
	—	−26.5	−2.0	−26.6	30.3
	—	33.3	27.6	4.2	20.0
	—	−0.9	0.0	0.0	0.0
	—	0.0	0.7	0.0	0.0
	—	0.0	−0.4	0.0	0.0
	—	0.9	0.4	0.2	0.2
	—	31.5	26.1	4.0	19.8
Cash from investing activities
	—	59.1	49.0	0.0	0.0
	—	−0.6	0.4	3.6	0.1
	—	0.0	0.0	0.0	3.1
	—	−0.1	0.2	0.0	0.0
	—	0.7	0.6	0.2	0.3
	—	2.6	−3.4	−20.4	−12.3
	—	−56.4	−51.2	−16.6	−8.8
Cash from financing activities
	—	18.2	0.0	0.0	0.0
	—	0.0	0.0	6.0	0.0
	—	0.0	0.0	95.0	0.0
	—	37.5	63.8	0.0	0.0
	—	0.0	0.0	48.6	12.5
	—	3.8	3.4	0.0	0.0
	—	—	—	0.0	3.0
	—	29.5	34.7	34.7	16.5
	—	0.0	0.0	3.1	0.0
	—	22.4	25.7	14.6	−32.0
	—	−2.4	0.7	1.9	−21.0
	—	−2.4	0.7	1.9	−21.0
	—	—	—	3.4	1.5
Reference items
	98.6	107	76.3	70.0	23.2
	15.1%	16.4%	12.7%	12.2%	4.6%
	−27.5	−27.5	−22.9	4.0	19.8
	—	−14.8	5.6	15.1	—
	−₹7.88	−₹7.88	−₹6.56	₹1.15	₹5.67
	—	0.48×	0.85×	0.13×	−1.90×
	—	0.9	0.4	0.2	0.2
	—	29.5	34.7	34.7	16.5

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

WANBURY₹177.84

Wanbury Limited

· Pharma & Health

₹ CrorePeersAHCL ANUHPHR BAJAJHCARE THEMISMED ZIMLAB LINCOLN SIGACHI VALIANTLABMcap ₹621 Cr

View

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation	12.4	13.0	13.3	14.3	—
+ Finance Costs	21.4	0.0	37.0	30.0	—
+ Interest Income	-0.4	-0.4	0.0	0.0	—
+ Fair Value (Gains) / Losses	0.0	0.0	-0.1	-0.0	—
+ Share-based Payments	0.9	0.0	1.1	1.6	—
+ Unrealised FX (Gain) / Loss	2.6	0.0	-0.2	-0.4	—
+ Other Non-cash Items	0.2	28.9	0.0	3.6	—
+ Other — Cash Effects are Investing / Financing	0.0	0.0	-2.0	0.0	—
+ Other Reconciling Items	0.0	-18.4	0.0	0.9	—
Changes in Working Capital
+ Inventories	27.7	14.0	-1.7	-12.9	—
+ Trade Receivables — Current	-5.3	0.0	-25.4	-26.3	—
+ Trade Receivables — Non-current	0.0	-20.3	0.0	0.0	—
+ Other Financial Assets — Current	0.3	0.0	-1.1	-0.5	—
+ Other Financial Assets — Non-current	-0.3	0.2	-0.1	0.0	—
+ Other Current Assets	4.9	-1.6	0.5	-8.4	—
+ Other Non-current Assets	0.0	0.0	-1.0	1.0	—
+ Trade Payables — Current	-26.6	-5.0	-22.1	-32.0	—
+ Other Financial Liabilities — Current	-3.7	-32.1	0.1	-1.4	—
+ Other Financial Liabilities — Non-current	0.0	0.0	-1.6	0.9	—
+ Other Current Liabilities	-5.4	-5.9	-0.6	-1.2	—
+ Provisions — Current	-0.3	0.4	0.5	2.2	—
+ Provisions — Non-current	1.9	0.6	1.4	2.3	—
Cash from Operating Activities
Profit Before Tax (per I/S)	-10.3	30.8	29.6	59.8	50.8
+ Total Adjustments (incl. Working Capital)	30.3	-26.6	-2.0	-26.5	—
Cash from Operations (pre-tax)	20.0	4.2	27.6	33.3	—
+ Interest Received — Operating	0.0	0.0	0.0	-0.9	—
+ Interest Paid — Operating	0.0	0.0	0.7	0.0	—
+ Other Inflows / (Outflows) — Operating	0.0	0.0	-0.4	0.0	—
+ Income Taxes Paid	0.2	0.2	0.4	0.9	—
Cash from Operating Activities	19.8	4.0	26.1	31.5	—
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)	0.0	0.0	49.0	59.1	—
+ Disp of Fixed Assets	0.1	3.6	0.4	-0.6	—
+ Disp of Intangibles under Development	3.1	0.0	0.0	0.0	—
+ Disp of Investment Property	0.0	0.0	0.2	-0.1	—
+ Interest Received — Investing	0.3	0.2	0.6	0.7	—
+ Other Inflows / (Outflows) — Investing	-12.3	-20.4	-3.4	2.6	—
Cash from Investing Activities	-8.8	-16.6	-51.2	-56.4	—
Cash from Financing Activities
+ Proceeds from Issue of Shares	0.0	0.0	0.0	18.2	—
+ Proceeds from Other Equity Instruments	0.0	6.0	0.0	0.0	—
+ Proceeds from Debentures / Notes / Bonds	0.0	95.0	0.0	0.0	—
+ Proceeds from Borrowings	0.0	0.0	63.8	37.5	—
+ Repayment of Borrowings	12.5	48.6	0.0	0.0	—
+ Payment of Lease Liabilities	0.0	0.0	3.4	3.8	—
+ Payment of Finance Lease Liabilities	3.0	0.0	—	—	—
+ Interest Paid	16.5	34.7	34.7	29.5	—
+ Dividends Paid	0.0	3.1	0.0	0.0	—
Cash from Financing Activities	-32.0	14.6	25.7	22.4	—
Net Changes in Cash (pre-FX)	-21.0	1.9	0.7	-2.4	—
Net Changes in Cash	-21.0	1.9	0.7	-2.4	—
Closing Cash	1.5	3.4	—	—	—
Reference Items
EBITDA	23.2	70.0	76.3	106.8	98.6
EBITDA Margin %	4.64	12.16	12.73	16.42	15.10
Free Cash Flow (CFO − Capex)	19.8	4.0	-22.9	-27.5	-27.5
Free Cash Flow to Equity	—	15.1	5.6	-14.8	—
Free Cash Flow per Basic Share	5.67	1.15	-6.56	-7.88	-7.88
Cash Flow to Net Income	-1.90	0.13	0.85	0.48	—
Cash Paid for Taxes	0.2	0.2	0.4	0.9	—
Cash Paid for Interest	16.5	34.7	34.7	29.5	—

As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.